Showing results (441-450 of 490) with videos related to
Sort By:
Pageof 49
Frontiers in Cell and Developmental Biology|November 1, 2021
Caffeine Inhibits Choroidal Neovascularization Through Mitigation of Inflammatory and Angiogenesis ActivitiesChristine M Sorenson, Yong-Seok Song, Ismail S Zaitoun, et al.Clinical Transplantation|March 10, 2021
Transplant outcomes using kidneys from high KDPI acute kidney injury donorsCaroline C Jadlowiec, Wael A Hanna, Jacob Ninan, et al.Congestive Heart Failure (Greenwich, Conn.)|January 27, 2012
Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failureMazen A Hanna, W H Wilson Tang, Boon W Teo, et al.Biorxiv : the Preprint Server for Biology|August 12, 2025
Canonical microRNA loss drives tumor development implicating therapeutic efficacy of enoxacin in angiosarcomaAnt Murphy, Bozhi Liu, Annaleigh Benton, et al.Radiation Oncology (London, England)|December 10, 2013
Outcomes of high-dose intensity-modulated radiotherapy alone with 1 cm planning target volume posterior margin for localized prostate cancerRafael Gadia, Élton T Leite, Flavia G Gabrielli, et al.Journal of the American College of Cardiology|April 5, 2008
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonanceA Selcuk Adabag, Barry J Maron, Evan Appelbaum, et al.Journal of Clinical Microbiology|February 13, 1999
Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteriaB A Hanna, A Ebrahimzadeh, L B Elliott, et al.Schizophrenia Research|September 23, 2018
A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidoneDelbert G Robinson, Juan A Gallego, Majnu John, et al.Journal of Neurosurgery|September 29, 2018
Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson's disease: long-term outcomes with up to 7 years of follow-upJoshua A Hanna, Tyler Scullen, Lora Kahn, et al.Journal of Neuro-Oncology|June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastomaJ F de Groot, M R Gilbert, K Aldape, et al.Pageof 49